A multicenter, double-blind, randomized 2x2 factorial design study to compare the efficacy of early (<6 hours) versus late (24-48 hours) ACE-inhibition and to compare the efficacy of Zofenopril and Lisinopril on oxidative reperfusion injury after a first acute anterior myocardial infarction: the ZAAMIS (Zofenopril After Acute Myocardial Infarction Study).

Trial Profile

A multicenter, double-blind, randomized 2x2 factorial design study to compare the efficacy of early (<6 hours) versus late (24-48 hours) ACE-inhibition and to compare the efficacy of Zofenopril and Lisinopril on oxidative reperfusion injury after a first acute anterior myocardial infarction: the ZAAMIS (Zofenopril After Acute Myocardial Infarction Study).

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 08 Aug 2014

At a glance

  • Drugs Zofenopril (Primary) ; Lisinopril
  • Indications Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms ZAAMIS
  • Sponsors Menarini
  • Most Recent Events

    • 07 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top